Abstract
Gastroesophageal reflux disease is the most common gastrointestinal diagnosis recorded during visits to outpatient clinics. The spectrum of injury includes esophagitis, stricture, the development of columnar metaplasia in place of the normal squamous epithelium (Barrett’s esophagus), and adenocarcinoma. Barrett’s esophagus is a premalignant lesion detected in the majority of patients with esophageal and gastroesophageal adenocarcinoma. The incidence of these cancers has been increasing in the United States and they are associated with a low rate of survival (5-year survival rate, 15–20%). When symptoms of gastroesophageal reflux disease are typical and the patient responds to therapy, no diagnostic tests are necessary to verify the diagnosis. Endoscopy is the primary test in patients whose condition is resistant to empirical therapy but its yield in this setting is low because of the poor correlation between symptoms attributed to the condition and endoscopic features of the disease. Clinical experience suggests that lifestyle modifications may be beneficial for gastroesophageal reflux disease although trials of the clinical efficacy of dietary or behavioral changes are lacking. Abundant data from randomized trials show benefits of inhibiting gastric acid secretion and suggest that proton-pump inhibitors are superior to H2-blockers and that both are superior to placebo. In patients with Barrett’s esophagus, antireflux interventions are intended to control symptoms of reflux and promote healing of the esophageal mucosa. If a patient has symptoms refractory to proton-pump inhibitors or cannot tolerate such therapy, antireflux surgery, most commonly Nissen fundoplication, may be an alternative management approach. In patients with high-grade dysplasia, endoscopic therapies or surgical resection must be considered.
Similar content being viewed by others
References
Camilleri M, Dubois D, Coulie B et al (2005) Prevalence and socioeconomic impact of functional gastrointestinal disorders in the United States: results from the US upper gastrointestinal study. Clin Gastroenterol Hepatol 3:543–552
Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R (2006) The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101:1900–1920
Rex DK, Cummings OW, Shaw M et al (2003) Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125:1670–1677
Ronkainen J, Aro P, Storskrubb T et al (2005) Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology 129:1825–1831
Kubo A, Levin TR, Block G et al (2009) Alcohol types and sociodemographic characteristics as risk factors for Barrett’s esophagus. Gastroenterology 136:806–815
Forman D (2005) Re: the role of over diagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:1013–1014
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249
Sharma P, McQuaid K, Dent J et al (2004) A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago workshop. Gastroenterology 127:310–330
DeVault KR, Castell DO (2005) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100:190–200
Armstrong D, Marshall JK, Chiba N et al (2005) Canadian consensus conference on the management of gastroesophageal reflux disease in adults—update 2004. Can J Gastroenterol 19:15–35
Kahrilas PJ, Shaheen NJ, Vaezi M et al (2008) AGAI medical position statement: management of gastroesophageal reflux disease. Gastroenterology 135:1383–1391
Kahrilas PJ, Shaheen NJ, Vaezi M (2008) AGAI technical review: management of gastroesophageal reflux disease. Gastroenterology 135:1392–1413
Hirota WK, Zuckerman MJ, Adler DG et al (2006) ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 63:570–580
Wang KK, Sampliner RE (2008) Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 103:788–797
Society for Surgery of the Alimentary Tract (2007) SSAT patient care guidelines: management of Barrett’s esophagus. J Gastrointest Surg 11:1213–1215
Kahrilas PJ (2008) Gastroesophageal reflux disease. N Engl J Med 359:1700–1707
Rabinovitch PS, Longton G, Blount PL, Levine DS, Reid BJ (2001) Predictors of progression in Barrett’s esophagus III: baseline flow cytometric variables. Am J Gastroenterol 96:3071–3083
Sharma P, Dent J, Armstrong D et al (2006) The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 131:1392–1399
Abela JE, Going JJ, Mackenzie JF, McKernan M, O’Mahoney S, Stuart RC (2008) Systematic four-quadrant biopsy detects Barrett’s dysplasia in more patients than non-systematic biopsy. Am J Gastroenterol 103:850–855
Wolfsen HC, Crook JE, Krishna M et al (2008) Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett’s esophagus. Gastroenterology 135:24–31
Cooper GS, Kou TD, Chak A (2009) Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends. Am J Gastroenterol 104:1356–1362
Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA (2002) Surveillance and survival in Barrett’s adenocarcinoma: a population-based study. Gastroenterology 122:633–640
Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE (2006) Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin Gastroenterol Hepatol 4:566–572
Wani S, Mathur S, Sharma P (2009) How to manage a Barrett’s esophagus patient with low-grade dysplasia. Clin Gastroenterol Hepatol 7:27–32
Wani S, Falk GW, Sampliner RE et al (2009) Low-grade dysplasia is a poor marker for cancer progression in patients with Barrett’s esophagus: preliminary results from a large, multi-center, cohort study. Gastroenterology 136:A592
Skacel M, Petras RE, Gramlich TL et al (2000) The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression. Am J Gastroenterol 95:3383–3387
Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P (2008) Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 67:394–398
Kaltenbach T, Crockett S, Gerson LB (2006) Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med 166:965–971
Khan M, Santana J, Donnellan C, Preston C, Moayyedi P (2007) Medical treatments in the short term management of reflux esophagitis. Cochrane Database Syst Rev 2:CD003244–CD003244
Dent J (2006) Review article: from 1906 to 2006—a century of major evolution of understanding of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 24:1269–1281
Klinkenberg-Knol EC, Nelis F, Dent J et al (2000) Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 118:661–679
Diav-Citrin O, Arnon J, Schechtman S et al (2005) The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther 21:269–275
Das D, Chilton AP, Jankowski JA (2009) Chemoprevention of oesophageal cancer and the AspECT trial. Recent Results Cancer Res 181:161–169
Finks JF, Wei Y, Birkmeyer JD (2006) The rise and fall of antireflux surgery in the United States. Surg Endosc 20:1698–1701
Vakil N, Shaw M, Kirby R (2003) Clinical effectiveness of laparoscopic fundoplication in a US community. Am J Med 114:1–5
Lundell L, Miettinen P, Myrvold HE et al (2007) Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux esophagitis. Br J Surg 94:198–203
Dominitz JA, Dire CA, Billingsley KG, Todd-Stenberg JA (2006) Complications and antireflux medication use after antireflux surgery. Clin Gastroenterol Hepatol 4:299–305
Spechler SJ, Lee E, Ahnen D et al (2001) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 285:2331–2338
Tran T, Spechler SJ, Richardson P, El-Serag HB (2005) Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a veterans affairs cohort study. Am J Gastroenterol 100:1002–1008
Attwood SE, Lundell L, Hatlebakk JG et al (2008) Medical or surgical management of GERD patients with Barrett’s esophagus: the LOTUS trial 3-year experience. J Gastrointest Surg 12:1646–1654
Corey KE, Schmitz SM, Shaheen NJ (2003) Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett’s esophagus? A meta-analysis. Am J Gastroenterol 98:2390–2394
Wani S, Sayana H, Sharma P (2010) Endoscopic eradication of Barrett’s esophagus. Gastrointest Endosc 71:147–166
Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB (2003) Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 98:1627–1633
Lagergren J, Bergström R, Lindgren A, Nyrén O (1999) Symptomatic gastroesophageal reflux disease as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825–831
Conio M, Bianchi S, Lapertosa G et al (2003) Long-term endoscopic surveillance of patients with Barrett’s esophagus: incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol 98:1931–1939
Watson A, Heading RC, Shepherd NA (2005) Guidelines for the diagnosis and management of Barrett’s columnar-lined oesophagus: a report of the working party of the British society of gastroenterology. British Society of Gastroenterology, London
Boyer J, Laugier R, Chemali M et al (2007) French society of digestive endoscopy SFED guideline: monitoring of patients with Barrett’s esophagus. Endoscopy 39:840–842
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vaira, D., Gatta, L., Ricci, C. et al. Gastroesophageal reflux disease and Barrett’s esophagus. Intern Emerg Med 6, 299–306 (2011). https://doi.org/10.1007/s11739-010-0427-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-010-0427-0